Investors in Akebia Therapeutics, Inc. AKBA need to pay close attention to the stock based on moves in the options market ...

Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.

Akebia Therapeutics (AKBA) has been on a downward spiral lately with significant selling pressure. After declining 39.9% over the past four weeks, the stock looks well positioned for a trend reversal ...

Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Airbus SE EADSY is an aerospace and defense company. The Zacks Consensus Estimate for its current year earnings has been ...

Akebia Therapeutics Inc. (Nasdaq: AKBA) is giving investors optimism due to recent surges and heavy trading activity. In fact, AKBA stock is one of the hottest penny stocks available at the moment.

Akebia Therapeutics, Inc.AKBA is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Akebia Therapeutics (AKBA) one of those stocks right now? A quick glance at the ...

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.